Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary objective of this trial is to evaluate the efficacy of Genotropin® treatment on height velocity SDS in short SGA children starting treatment at an age of 24-30 months as compared to untreated controls.
Inclusion criteria
- Short Stature children born small for Gestational Age (SGA)